Analysis of irrational drug use in patients with stable chronic obstructive pulmonary disease
10.11958/20170563
- VernacularTitle:慢性阻塞性肺疾病患者稳定期不合理用药情况分析
- Author:
jing Shui QIU
1
;
juan Li CHEN
;
Hui MA
;
xiang Yong ZHANG
;
Fang ZHAO
;
sheng Guang LI
;
feng Jian PAN
Author Information
1. 天津市胸科医院药剂科 300222
- Keywords:
pulmonary disease,chronic obstructive;
stable phase;
rational drug use
- From:
Tianjin Medical Journal
2017;45(10):1076-1079
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the standard prescription in patients with stable chronic obstructive pulmonary disease (COPD) and to provide a reference for rational drug use. Methods A total of 157 patients with COPD in our hospital were included into the study from June 2016 to January 2017. Of patients, there were 3 patients with mild airflow limitation, 18 patients with moderate airflow limitation, 39 patients with severe airflow limitation and 97 patients with extremely severe airflow limitation. The self-made questionnaire was used to understand the basic situation, complications and irrational drug use. Results Most severe and extremely severe COPD patients were male, and most of them combined with high blood pressure and cardiovascular disease. Of the 157 patients, 12 cases with moderate airflow limitation used inhaled therapy of corticosteroids/bronchodilator medications, 45 cases combined with pneumocardial disease used compound methoxyphenamine, 26 cases used leukotriene receptor antagonist, 14 cases used antibiotics for no obvious infection symptom and 11 cases used systemic corticosteroids in stable COPD. All of them belong to rational drug use. Conclusion There are some unreasonable situations of drug using in patients with stable COPD. The medical staff should strictly control indications, strengthen the education for drug use, guide rational drug use and avoid the occurrence of adverse consequences.
